Papillary fibroelastoma of the heart in a geriatric patient
Authors:
Markéta Dvořáková 1; Rita Šaková 1; Tomáš Richter 1; Eva Topinková 1,2
Authors‘ workplace:
Klinika geriatrie a interní medicíny 1. lékařské fakulty Univerzity Karlovy a Všeobecné fakultní nemocnice v Praze
1; Subkatedra geriatrie, Institut postgraduálního vzdělávání ve zdravotnictví
2
Published in:
Geriatrie a Gerontologie 2025, 14, č. 3: 137-142
Category:
doi:
https://doi.org/10.61568/geri/50-6575/20250909/141485
Overview
Papillary fibroelastoma (PFE) is a rare primary benign heart tumour most frequently located on heart valves. Its incidence increases with age and most PFE are diagnosed in older age groups. Despite its benign characteristics PFE may present with life threatening embolic events. With routine use of echocardiography and other imagining techniques PFE is diagnosed more frequently, often as an incident finding. Aetiology of PFE is unknown. Surgical treatment is a method of choice if the patient is otherwise able to withstand the surgical procedure. However, there are no recent evidence-based guidelines for PFE treatment due to its rare occurrence. The aim of the papers is to provide readers with the basic description of this rare tumour, which could be seen in geriatric practice. Further to present a case study of PFE in older patient who was treated in the Department of Geriatrics and Internal Medicine, 1st Faculty of Medicine, Charles University and General University Hospital in Prague.
Keywords:
echocardiography – Aortic valve – papillary fibroelastoma – cardioembolic events
Sources
1. Zoltowska DM, Sadic E, Becoats K, et al. Cardiac papillary fibroelastoma. J Geriatr Cardiol 2021; 18(5): 346–351.
2. Gowda RM, Khan IA, Nair CK, et al. Cardiac papillary fibroelastoma: a comprehensive analysis of 725 cases. Am Heart J 2003; 146(3): 404–410.
3. Troubil M, Němec P, Šantavý P, et al. Papilární fibroelastom aortální chlopně. Cor Vasa 2007; 49 (6): 226–228.
4. Neupane G, Sharma R, Parajuli R, et al. Cardiac papillary fibroelastoma and cerebrovascular events: a systematic review. CJC Open 2024; 6(11): 1259–1273.
5. Devanabanda AR, Lee LS. Papillary fibroelastoma 2023. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan. Dostupné z: www.ncbi.nlm.nih.gov/books/NBK549829/.
6. Tamin SS, Maleszewski JJ, Scott CG, et al. Prognostic and bioepidemiologic implications of papillary fibroelastomas. J Am Coll Cardiol 2015; 65(22): 2420–2429.
7. Urbanec T, Havránek S, Grus T, et al. Mnohočetný papilární fibroelastom jako zdroj kardioembolizační cévní mozkové příhody – kazuistika a přehled literatury. Cor et Vasa Case reports 2020; 3: e30–e35.
8. Jha NK, Khouri M, Murphy DM, et al. Papillary fibroelastoma of the aortic valve-a case report and literature review. J Cardiothorac Surg 2010; 5 : 84.
9. Bicer M, Cikirikcioglu M, Pektok E, et al. Papillary fibroelastoma of the left atrial wall: a case report. J Cardiothorac Surg 2009; 4 : 28.
Labels
Geriatrics General practitioner for adults Orthopaedic prostheticsArticle was published in
Geriatrics and Gerontology
2025 Issue 3
- Memantine in Dementia Therapy – Current Findings and Possible Future Applications
- Memantine Eases Daily Life for Patients and Caregivers
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole vs. Tramadol in Postoperative Analgesia
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
Most read in this issue
- Národní plán rozvoje geriatrické péče v České republice do roku 2035
- Papillary fibroelastoma of the heart in a geriatric patient
- Editorial